Home › Pneumococcal Infections › Texas › League City
Pneumococcal Infections clinical trials in League City, TX
3 studies for Pneumococcal Infections are looking for participants at sites in and around League City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
RecruitingPhase 1Healthy volunteers welcome
- University of Texas Medical Branch ( Site 1020), League City
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
RecruitingPhase 3Healthy volunteers welcome
- University of Texas Medical Branch, Sealy Institute for Vaccine Sciences Clinical Trials Program, Galveston · 23 mi away
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
RecruitingPhase 3Healthy volunteers welcome
- University of Texas Medical Branch,, League City
About Pneumococcal Infections
Pneumococcal infections can be mild or severe. The most common types of infections are Meningitis, Sepsis, Pneumonia, and ear and sinus infections
More about Pneumococcal Infections on MedlinePlus
Pneumococcal Infections trials in other cities
- Syracuse, NY4 studies
- Tampa, FL4 studies
- Miami, FL4 studies
- Birmingham, AL4 studies
- Simpsonville, SC4 studies
- Sugar Land, TX4 studies
- Hialeah, FL3 studies
- Shreveport, LA3 studies
- Cleveland, OH3 studies
- Ogden, UT3 studies
- Cincinnati, OH3 studies
- Idaho Falls, ID3 studies
Other studies in League City
- Non-Small Cell Lung Cancer15 studies
- Breast Cancer12 studies
- Metastatic Cancer7 studies
- Ulcerative Colitis6 studies
- Lung Cancer6 studies
- Colorectal Cancer6 studies
- Cancer (all types)5 studies
- Ovarian Cancer5 studies
- Stroke5 studies
- Bladder Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Prostate Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.